|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| Revenues | |||
| Lease operating expenses | |||
| General and administrative expenses | |||
| Depletion and accretion on discounted liabilities | |||
| Impairment expense | |||
| Total operating costs and expenses | |||
| Loss from operations | |||
| Other income and expense | |||
| Loss on disposition of proved reserves | |||
| Interest expense | |||
| Total other income (expense) | |||
| Net loss | |||
| Net loss per common share diluted | |||
| Net loss per common share basic | |||
| Weighted average number of common shares outstanding during the period diluted | |||
| Weighted average number of common shares outstanding during the period basic |
Loading...
